Design, Synthesis, and In-Silico Assessment of Imidazo[2,1-b]thiazol-5-amines for Promising Anti-Bacterial and Anti-Fungal Activity

Introduction: The imidazo[2,1-b]thiazole core structure has gained significant attention due to its biological activity in various bioactive compounds. Its derivatives exhibit antibacterial, anticancer, and anti-inflammatory properties. Based on an extensive literature review, the synthesis of novel imidazo[2,1-b]thiazole derivatives was undertaken to explore their antibacterial potential against resistant bacterial strains. Methods: The synthesis of the imidazo[2,1-b]thiazole derivatives was performed in three steps: Step 1: The reaction of 5-methylthiazol-2-amine with phenacyl bromide led to the formation of 2-methyl-6-phenylimidazo[2,1-b]thiazole. Step 2: This intermediate was then treated with N-bromo-succinimide (NBS) to form 5-bromo-2-methyl-6-phenylimidazo[2,1-b]thiazole. Step 3: The final derivatives, 5-bromo-2-methyl-6-phenylimidazo[2,1-b]thiazol-5-amine, were synthesized by fur-ther functionalization. The compounds were characterized using TLC, FTIR, 1H NMR, and ESI-MS. Their antibacterial activity was evaluated against Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Bacillus subtilis, Candida albicans, and Aspergillus niger. Results: The derivatives 6a, 6b, 6i, and 6o exhibited strong antibacterial activity, especially against P. aeruginosa and S. aureus, with zones of inhibition comparable to ciprofloxacin. Compounds 6a, 6b, 6j, 6l, and 6o also showed potent activity against E. coli and B. subtilis. Conversely, compounds 6c, 6e, 6i, 6j, 6l, 6n, along with 6o, showed highly potent antifungal properties against C. albicans and A. niger. Discussion: The synthesized imidazo[2,1-b]thiazole derivatives demonstrated significant antibac-terial and antifungal activity, notably against resistant pathogens, showing promise as alternative therapies. However, the lack of in vivo and mechanistic investigations restricts findings, requiring more study for clinical confirmation. Conclusion: The synthesized imidazo[2,1-b]thiazole derivatives exhibited significant antibacterial properties, making them promising candidates for further development as antibacterial agents.

Authors

Institutions

Publication Details

Journal
Current Organocatalysis
Published
2025-10-03
DOI
https://doi.org/10.2174/0122133372390562250916113218
Primary Topic
Synthesis and biological activity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Design, Synthesis, and In-Silico Assessment of Imidazo[2,1-b]thiazol-5-amines for Promising Anti-Bacterial and Anti-Fungal Activity

Ajay Sharma, Sameer Rastogi, Mohit Gupta, Babita Sharma et al.
Current Organocatalysis
Synthesis and biological activity
article

Design, Synthesis, and In-Silico Assessment of Imidazo[2,1-b]thiazol-5-amines for Promising Anti-Bacterial and Anti-Fungal Activity

Ajay Sharma, Sameer Rastogi, Mohit Gupta, Babita Sharma, Saurabh Bhardwaj, Shivendra Kumar, Shivani Sharma
article en

Abstract

Introduction: The imidazo[2,1-b]thiazole core structure has gained significant attention due to its biological activity in various bioactive compounds. Its derivatives exhibit antibacterial, anticancer, and anti-inflammatory properties. Based on an extensive literature review, the synthesis of novel imidazo[2,1-b]thiazole derivatives was undertaken to explore their antibacterial potential against resistant bacterial strains. Methods: The synthesis of the imidazo[2,1-b]thiazole derivatives was performed in three steps: Step 1: The reaction of 5-methylthiazol-2-amine with phenacyl bromide led to the formation of 2-methyl-6-phenylimidazo[2,1-b]thiazole. Step 2: This intermediate was then treated with N-bromo-succinimide (NBS) to form 5-bromo-2-methyl-6-phenylimidazo[2,1-b]thiazole. Step 3: The final derivatives, 5-bromo-2-methyl-6-phenylimidazo[2,1-b]thiazol-5-amine, were synthesized by fur-ther functionalization. The compounds were characterized using TLC, FTIR, 1H NMR, and ESI-MS. Their antibacterial activity was evaluated against Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Bacillus subtilis, Candida albicans, and Aspergillus niger. Results: The derivatives 6a, 6b, 6i, and 6o exhibited strong antibacterial activity, especially against P. aeruginosa and S. aureus, with zones of inhibition comparable to ciprofloxacin. Compounds 6a, 6b, 6j, 6l, and 6o also showed potent activity against E. coli and B. subtilis. Conversely, compounds 6c, 6e, 6i, 6j, 6l, 6n, along with 6o, showed highly potent antifungal properties against C. albicans and A. niger. Discussion: The synthesized imidazo[2,1-b]thiazole derivatives demonstrated significant antibac-terial and antifungal activity, notably against resistant pathogens, showing promise as alternative therapies. However, the lack of in vivo and mechanistic investigations restricts findings, requiring more study for clinical confirmation. Conclusion: The synthesized imidazo[2,1-b]thiazole derivatives exhibited significant antibacterial properties, making them promising candidates for further development as antibacterial agents.

Current OrganocatalysisVol. 12
Uttarakhand Technical University (IN), Rajiv Gandhi University of Health Sciences (IN), Kanya Maha Vidyalaya (IN), National Institute of Technology Hamirpur (BD), Noida International University (IN), Indo Soviet Friendship College of Pharmacy (IN), Sharda University (IN), Dehradun Institute of Technology University (IN)
Openalex Percentile: Top 79%
Synthesis and biological activity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.